Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells

Chimeric antigen receptor (CAR) redirected T cells are potent therapeutic options against hematological malignancies. The current dominant manufacturing approach for CAR T cells depends on retroviral transduction. With the advent of gene editing, insertion of a CD19-CAR into the T cell receptor (TCR...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Jonas Kath, Weijie Du, Alina Pruene, Tobias Braun, Bernice Thommandru, Rolf Turk, Morgan L. Sturgeon, Gavin L. Kurgan, Leila Amini, Maik Stein, Tatiana Zittel, Stefania Martini, Lennard Ostendorf, Andreas Wilhelm, Levent Akyüz, Armin Rehm, Uta E. Höpken, Axel Pruß, Annette Künkele, Ashley M. Jacobi, Hans-Dieter Volk, Michael Schmueck-Henneresse, Renata Stripecke, Petra Reinke, Dimitrios L. Wagner
格式: Artigo
語言:Inglês
出版: Elsevier 2022-06-01
叢編:Molecular Therapy: Methods & Clinical Development
主題:
gene editing
CRISPR-Cas9
chimeric antigen receptor
non-viral cell manufacturing
CAR T cells
TRAC
在線閱讀:http://www.sciencedirect.com/science/article/pii/S2329050122000511
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍